Several studies have shown that Gal-3 expression is part of an adaptive response that protects GBM cells from death under hypoxia, explaining why mesenchymal GSCs, found in the hypoxic and necrotic areas, express a higher level of Gal-3 compared to other GSC subtypes23,24. The gene discussed is LGALS3; the disease is glioblastoma.